Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use

AIDS

Volumn 15, Issue 3, 2001, Pages 423-424

  Palepu, Anita ^a   Yip, Benita ^a   Miller, Cari ^a   Strathdee, Steffanie A ^a,b   O'Shaughnessy, Michael V ^a   Montaner, Julio S G ^a   Hogg, Robert S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS LOAD;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; GUIDELINES; HIV INFECTIONS; HUMANS; PATIENT COMPLIANCE; SUBSTANCE ABUSE, INTRAVENOUS; VIRAL LOAD;

EID: 0035895658     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200102160-00021     Document Type: Article

References (4)

1. Barriers to use of free antiretroviral therapy in injection drug users
2. Self-reported antiretroviral therapy in injection drug users
3. A comparison of exposure groups in the EuroSIDA study: Starting highly active antiretroviral therapy (HAART), response to HAART, and survival
4. Access to antiretroviral treatment among French HIV infected injection drug users: The influence of continued drug use